Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Universal Ibogaine Inc
XTSX:IBO

Watchlist Manager
Universal Ibogaine Inc Logo
Universal Ibogaine Inc
XTSX:IBO
Watchlist
Price: 0.005 CAD -50%
Market Cap: CA$1.6m
Write Note Create Alert Ask AI

Universal Ibogaine Inc
Investor Relations

Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is focused on developing medicines and building a network of holistic recovery clinics for the treatment of addictions. The company treats addictions primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. Its focuses on developing ibogaine for the treatment of opioid use disorders. Ibogaine is a neuroactive compound, which is derived from various plants. Ibogaine helps to repair damaged brain tissues of the patients and helps them to recover and rebuild their lives.

Show more
Loading
IBO
S&P TSX Composite Index (Canada)
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Nicholas Peter Karos
CEO, Director of Capital Markets & Director
No Bio Available
Mr. Greg J. Leavens C.A., CPA
CFO & Corporate Secretary
No Bio Available
Mr. Shayne Nyquvest
Co-Founder
No Bio Available
Mr. Dugan Selkirk
Manager Communications & Investor Relations
No Bio Available
Cathy Fernandes
VP of Marketing & VP of Communications
No Bio Available

Contacts

Address
ALBERTA
Calgary
1414 8 St SW Suite 610
Contacts
+14038701841.0
www.p2renewables.com
sparklesyt

See Also

Summary
IBO intrinsic value, competitors valuation, and company profile.
DCF Valuation
IBO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IBO stock valuation using valuation multiples.
Wall Street Estimates
IBO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IBO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.